Sanofi buys into Indian biotech
Sanofi-Aventis, France’s largest drugmaker, has made its first direct investment in the Indian biotech sector with the acquisition of a 78 per cent stake in Shantha Biotechnics, an Indian vaccine maker, for €429m ($613m).
http://www.ft.com/cms/s/0/4f13effe-7b0d-11de-8c34-00144feabdc0.html
Posted via email from French BioBeach
YEi invites US resident entrepreneurs who are starting or have recently started high-tech ventures with international appeal to participate in its annual competition.
The French Embassy Office for Science and Technology and top innovation network partners in France will provide selected candidates with a valuable opportunity to meet potential business partners in France along with [...]
2009 French American Innovation Day “Theranostics and Biology: Know-How Challenges, Applications & Breakthroughs”
Call for projects
The call for innovative and entrepreneurial projects in the field of “Theranostics and Biology: Know-How Challenges, Applications and Breakthroughs” is jointly launched by Mérieux Alliance and the French Consulate in Boston and will reward best project(s) with a Mérieux Research Grant [...]
Check KPBS interview of Duane Roth, the CEO of Connect.
According to Duane, the venture capital funding model for biotechs in San Diego will never be as before.
http://www.kpbs.org/news/2009/jul/31/san-diego-biotech-looks-new-approach/
Last Wednesday, Entrepreneur Magazine published a list of great cities to start your business and San Diego was ranked 4th after Las Vegas, Portland and Orlando, Florida.
Ranking factors were government incentives, population growth, affordability of commercial rents and openness to new ideas.
Fostering collaborative research, tech transfer and spin off projects, thus addressing the needs of European Biotech enterprises is the service that EuroBiO is willing to propose to the life sciences community.
